News

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...
Spokane's Gestalt Diagnostics lands $7.5M in funding to enhance its AI tools for digital pathology, aiming to improve cancer ...
RESTON, VA / ACCESS Newswire / April 29, 2025 /Leidos (NYSE:LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with ...
Spotlight Pathology, a Manchester-based MedTech company developing AI-powered pathology tools, has secured £425,000 from ...
US-based Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow ...
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...
The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...
The National Academy of Sciences announced today the election of 120 members and 30 international members in recognition of ...
Students seeking careers in health care field have several options for education here in Tahlequah, from certified nursing assistant to full-fledged medical doctor of osteopathic medicine. Students at ...
The seminars are scheduled to take place from 3:30-5 p.m. today, Tuesday, April 29. A social period will precede the seminar at 3:20 p.m., with light snacks inside the lecture room.
He holds a medical degree, master’s, and bachelor’s from Wayne State University, and is board-certified in both anatomic and forensic pathology.
"This FDA Breakthrough Device Designation underscores the potential of our computational pathology platform to enable more personalised treatment decisions for people with cancer,” said Susan ...